Response | TAX → FEC | FEC → TAX | Total (all women) |
---|
cPR | 6/31 (19) | 8/29 (28) | 14/60 (23) |
pPR | 9/31 (29) | 9/29 (31) | 18/60 (30) |
mPR | 16/31 (52) | 12/29 (41) | 28/60 (47) |
- Number of tumours classified as a complete pathological response (cPR), partial pathological response (pPR) or minor pathological response (mPR) after completion of neoadjuvant chemotherapy according to drug regimen. Data presented as n/N (%). TAX, docetaxel (Taxotere®); FEC, combined flourouracil-epirubicin-cyclophosphamide anthracycline-based chemotherapy.